The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

NCT06365762 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Age Related Cataracts

Interventions

DRUG: EDTA Ophthalmic Solution 2.6%
DRUG: EDTA Ophthalmic Solution 1.3%
DRUG: Saline Solution (Placebo)

Sponsor

Livionex Inc.